Whitmore-Jewett staging system

Whitmore-Jewett Staging System

The Whitmore-Jewett Staging System is a classification system used in the field of oncology to stage prostate cancer. It was developed by Willet F. Whitmore Jr. and Herman H. Jewett, two renowned urologists in the mid-20th century. The system is based on the extent of the tumor, the involvement of lymph nodes, and the presence of distant metastasis.

Overview

The Whitmore-Jewett Staging System classifies prostate cancer into four stages: A, B, C, and D. Each stage is further subdivided based on the extent of the tumor, the involvement of lymph nodes, and the presence of distant metastasis.

• Stage A: The cancer is confined to the prostate and is not detectable by physical examination or imaging tests. It is usually found incidentally during surgery for other conditions, such as benign prostatic hyperplasia (BPH).
• Stage B: The cancer is still confined to the prostate but is detectable by physical examination or imaging tests.
• Stage C: The cancer has spread beyond the prostate to nearby tissues, such as the seminal vesicles.
• Stage D: The cancer has spread to distant parts of the body, such as the lymph nodes, bones, or other organs.

Comparison with Other Staging Systems

The Whitmore-Jewett Staging System is similar to the TNM staging system, another widely used system for staging prostate cancer. However, the Whitmore-Jewett system uses a simpler, more straightforward approach, making it easier for patients to understand their diagnosis and prognosis.

See Also

• Prostate cancer
• Cancer staging
• TNM staging system

References

Whitmore-Jewett staging system Resources
Latest articles Most recent articles Ongoing trials	Wikipedia